The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Anderson, E. N. (1977) · eScholarship (California Digital Library) · Cited by 2,567
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Scatter factor/hepatocyte growth factor is essential for liver development
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., & Birchmeler, C. (1995) · Nature · doi:10.1038/373699a0 · Cited by 1,394
Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., & Comoglio, P. M. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.629 · Cited by 1,337
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G., & Comoglio, P. M. (1994) · Cell · doi:10.1016/0092-8674(94)90318-2 · Cited by 991
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Sonnenberg, E., Meyer, D., Weidner, K. M., & Birchmeier, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.223 · Cited by 698
Scatter factor induces blood vessel formation in vivo.
Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., & Rosen, E. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1937 · Cited by 691
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.
Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., & Michalopoulos, G. K. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07836.x · Cited by 660
Emerging Multipotent Aspects of Hepatocyte Growth Factor
Matsumoto, K., & Nakamura, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021283 · Cited by 660
Weidner, K. M., Di Cesare, S., Sachs, M., Brinkmann, V., Behrens, J., & Birchmeier, W. (1996) · Nature · doi:10.1038/384173a0 · Cited by 576
Mechanism of met oncogene activation
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., & Vande Woude, G. F. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 560
Regulation of Scatter Factor/Hepatocyte Growth Factor Responses by Ras, Rac, and Rho in MDCK Cells
Ridley, A. J., Comoglio, P. M., & Hall, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1110 · Cited by 535
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
Boccaccio, C., Andò, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., & Comoglio, P. M. (1998) · Nature · doi:10.1038/34657 · Cited by 519
c-Met: Structure, functions and potential for therapeutic inhibition
Ma, P. C., Maulik, G., Christensen, J., & Salgia, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023768811842 · Cited by 504
Self-citationNovel mutations of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202547 · Cited by 497
Christensen, J. G., Schreck, R., Burrows, J., Kuruganti, P. A., Chan, E., Le, P., Chen, J., Wang, X., Ruslim, L., Blake, R. A., et al. (2003) · PubMed · Cited by 497
Self-citationNakajima, M., Sawada, H., Yamada, Y., Watanabe, A., Tatsumi, M., Yamashita, J., Matsuda, M., Sakaguchi, T., Hirao, T., & Nakano, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990501)85:9%3c1894::aid-cncr3%3e3.0.co;2-j · Cited by 494
Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Renzo, M. F. D., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Médico, E., Gaglia, P., Zara, P., & Comoglio, P. M. (1991) · PubMed · Cited by 474
Renzo, M. F. D., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., & Giordano, S. (1995) · PubMed · Cited by 471
Ma, P. C., Kijima, T., Maulik, G., Fox, E. A., Sattler, M., Griffin, J. D., Johnson, B. E., & Salgia, R. (2003) · PubMed · Cited by 454
Self-citationVan Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.4.381 · Cited by 445
The Semaphorin 4D receptor controls invasive growth by coupling with Met
Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L., & Comoglio, P. M. (2002) · Nature Cell Biology · doi:10.1038/ncb843 · Cited by 444
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442
Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.701 · Cited by 440
A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00567-0 · Cited by 420
Xiao, G.-H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011532898 · Cited by 417
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
Furge, K. A., Zhang, Y.-W., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203859 · Cited by 410
Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N., & Gerritsen, M. E. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64058-8 · Cited by 396
Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., & Salgia, R. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00029-6 · Cited by 391
Self-citationThe ‘Gab’ in signal transduction
Gu, H., & Neel, B. G. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00002-3 · Cited by 388
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Zhang, Y.-W., Su, Y., Volpert, O. V., & Woude, G. F. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135113100 · Cited by 348
Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells*
Jo, M., Stolz, D. B., Esplen, J. E., Dorko, K., Michalopoulos, G. K., & Strom, S. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8806 · Cited by 347
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey, P. A., Zhu, X., Zarnegar, R., Swanson, P. E., Ratliff, T. L., Vollmer, R. T., & Day, M. L. (1995) · Europe PMC (PubMed Central) · Cited by 335
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203455 · Cited by 332
A novel germ line juxtamembrane Met mutation in human gastric cancer
Lee, J.-H., Han, S.-U., Cho, H., Jennings, B., Gerrard, B., Dean, M., Schmidt, L., Zbar, B., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203874 · Cited by 329
Frequent amplification of the c-met gene in scirrhous type stomach cancer
Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., & Tahara, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91548-5 · Cited by 328
Potempa, S., & Ridley, A. J. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.8.2185 · Cited by 327
Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E. O., Hudson, E. A., Resau, J. H., & Woude, G. F. V. (1997) · PubMed · Cited by 320
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., & Vande Woude, G. F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5152 · Cited by 312
Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
Neckers, L., Schulte, T. W., & Mimnaugh, E. (1999) · Investigational New Drugs · doi:10.1023/a:1006382320697 · Cited by 301
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
Michieli, P., Mazzone, M., Basilico, C., Cavassa, S., Sottile, A., Naldini, L., & Comoglio, P. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.032 · Cited by 299
Yamashita, J.-I., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., & Shin, S.-I. (1994) · PubMed · Cited by 298
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
Dong, G., Chen, Z., Li, Z. Y., Yeh, N. T., Bancroft, C. C., & Waes, C. V. (2001) · PubMed · Cited by 283
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
Royal, I., Lamarche-Vane, N., Lamorte, L., Kaibuchi, K., & Park, M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1709 · Cited by 277
C-met Proto-Oncogene Expression in Benign and Malignant Human Prostate Tissues
Pisters, L. L., Troncoso, P., Zhau, H. E., Li, W., von Eschenbach, A. C., & Chung, L. W. K. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67297-5 · Cited by 269
Otsuka, T., Takayama, H., Sharp, R., Celli, G. B., LaRochelle, W. J., Bottaro, D. P., Ellmore, N., Vieira, W., Owens, J. W., Anver, M. R., et al. (1998) · PubMed · doi:10.5281/zenodo.894795 · Cited by 268
Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer
Jiang, W. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00019-5 · Cited by 264
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer.
Renzo, M. F. D., Poulsom, R., Olivero, M., et al. (1995) · PubMed · Cited by 262
Essential Role of Gab1 for Signaling by the C-Met Receptor in Vivo
Sachs, M., Brohmann, H., Zechner, D., Müller, T., Hülsken, J., Walther, I., Schaeper, U., Birchmeier, C., & Birchmeier, W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1375 · Cited by 258
Park, W. S., Dong, S. M., Kim, S. Y., Na, E. Y., Shin, M. S., Pi, J. H., Kim, B. J., Bae, J. H., Hong, Y. K., Lee, K. S., et al. (1999) · PubMed · Cited by 251
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A., & Elliott, B. E. (1996) · Europe PMC (PubMed Central) · Cited by 244
Crystal structure of the HGF β‐chain in complex with the Sema domain of the Met receptor
Stamos, J., Lazarus, R. A., Yao, X., Kirchhofer, D., & Wiesmann, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600243 · Cited by 240
BindingDB (2025) · PubMed · doi:10.7270/q2dv1qm3 · Cited by 235
van der Voort, R., Taher, T. E. I., Wielenga, V. J. M., Spaargaren, M., Prevo, R., Smit, L., David, G., Hartmann, G., Gherardi, E., & Pals, S. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6499 · Cited by 232
Takeuchi, H., Bilchik, A. J., Saha, S., Turner, R. R., Wiese, D., Tanaka, M., Kuo, C. T., Wang, H. J., & Hoon, D. S. �. (2003) · PubMed · Cited by 232
Ueki, T., Fujimoto, J., Suzuki, T., Yamamoto, H., & Okamoto, E. (1997) · Hepatology · doi:10.1002/hep.510250413 · Cited by 226
The mutationally activated Met receptor mediates motility and metastasis
Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S., & Vande Woude, G. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14417 · Cited by 224
Tamura, M., Arakaki, N., Tsubouchi, H., Takada, H., & Daikuhara, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53072-6 · Cited by 222
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
Date, K., Matsumoto, K., Shimura, H., Tanaka, M., & Nakamura, T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01475-0 · Cited by 217
Expression of c-met is a strong independent prognostic factor in breast carcinoma
Ghoussoub, R. A. D., Dillon, D. A., D'Aquila, T., Rimm, E. B., Fearon, E. R., & Rimm, D. L. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7 · Cited by 217
Elevated Serum Concentrations of Hepatocyte Growth Factor in Patients With Multiple Myeloma
Seidel, C., Børset, M., Turesson, I., Abildgaard, N., Sundan, A., & e Nordic Myeloma Study Group, A. W. F. T. (1998) · Blood · doi:10.1182/blood.v91.3.806 · Cited by 214
Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., & Nakamura, T. (2000) · PubMed · Cited by 214
Khwaja, A., Lehmann, K., Marte, B. M., & Downward, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18793 · Cited by 213
Cao, B., Su, Y., Oskarsson, M., Zhao, P., Kort, E. J., Fisher, R. J., Wang, L.-M., & Vande Woude, G. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131200498 · Cited by 213
Overexpression of theMET/HGF receptor in ovarian cancer
Di Renzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P., & Comoglio, P. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580507 · Cited by 212
The Met Proto-Oncogene Mesenchymal to Epithelial Cell Conversion
Tsarfaty, I., Rong, S., Resau, J. H., Rulong, S., da Silva, P. P., & Vande Woude, G. F. (1994) · Science · doi:10.1126/science.7505952 · Cited by 211
The Sema domain of Met is necessary for receptor dimerization and activation
Kong-Beltran, M., Stamos, J., & Wickramasinghe, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.013 · Cited by 209
Natali, P., Nicotra, M., Di Renzo, M., Prat, M., Bigotti, A., Cavaliere, R., & Comoglio, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.422 · Cited by 205
Ichimura, E., Maeshima, A., Nakajima, T., & Nakamura, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03111.x · Cited by 201
Olivero, M., Rizzo, M., Madeddu, R., Casadio, C., Pennacchietti, S., Nicotra, M., Prat, M., Maggi, G., Arena, N., Natali, P., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.646 · Cited by 199
Maroun, C. R., Holgado-Madruga, M., Royal, I., Naujokas, M. A., Fournier, T. M., Wong, A. J., & Park, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1784 · Cited by 196
Schmidt, L., Junker, K., Weirich, G., Glenn, G., Choyke, P., Lubensky, I., Zhuang, Z., Jeffers, M., Woude, G. V., Neumann, H., et al. (1999) · The Journal of Urology · doi:10.1097/00005392-199905000-00137 · Cited by 189
Abounader, R., Lal, B., Luddy, C., Koe, G., Davidson, B., Rosen, E. M., & Laterra, J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0421fje · Cited by 186
The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.
Naldini, L., Vigna, E., Ferracini, R., Longati, P., Gandino, L., Prat, M., & Comoglio, P. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1793 · Cited by 185
Cross-talk between the proto-oncogenes Met and Ron
Follenzi, A., Bakovic, S., Gual, P., Stella, M. C., Longati, P., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203620 · Cited by 183
Hara, T., Ooi, A., Kobayashi, M., Mai, M., Yanagihara, K., & Nakanishi, I. (1998) · PubMed · Cited by 183
Berthou, S., Aebersold, D. M., Schmidt, L. S., Stroka, D., Heigl, C., Streit, B., Stalder, D., Gruber, G., Liang, C., Howlett, A. R., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207691 · Cited by 178
Abounader, R., Ranganathan, S., Lal, B., Fielding, K., Book, A., Dietz, H., Burger, P., & Laterra, J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1548 · Cited by 177
Date, K., Matsumoto, K., Kuba, K., Shimura, H., Tanaka, M., & Nakamura, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202231 · Cited by 176
Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M. K., Sausville, E. A., Monks, A. P., & Woude, G. F. V. (2000) · PubMed · Cited by 168
Expression of scatter factor and c‐ met receptor in benign and malignant breast tissue
Jin, L., Fuchs, A., Schnitt, S. J., Yao, Y., Joseph, A., Lamszus, K., Park, M., Goldberg, I. D., & Rosen, E. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<749::aid-cncr12>3.0.co;2-# · Cited by 164
Siegfried, J. M., Weissfeld, L. A., Singh-Kaw, P., Weyant, R. J., Testa, J. R., & Landreneau, R. J. (1997) · PubMed · Cited by 164
C-terminal truncated forms of Met, the hepatocyte growth factor receptor.
Prat, M., Crepaldi, T., Gandino, L., Giordano, S., Longati, P., & Comoglio, P. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.5954 · Cited by 163
Expression of the C-Met/HGF receptor in human breast carcinoma: Correlation with tumor progression
Beviglia, L., Matsumoto, K., Lin, C.-S., Ziober, B. L., & Kramer, R. H. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<301::aid-ijc12>3.0.co;2-e · Cited by 161
Gual, P., Giordano, S., Williams, T. A., Rocchi, S., Van Obberghen, E., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203514 · Cited by 160
Fan, S., Ma, Y. X., Wang, J.-A., Yuan, R.-Q., Meng, Q., Cao, Y., Laterra, J. J., Goldberg, I. D., & Rosen, E. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203566 · Cited by 159
NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
Matsumoto, K., & Nakamura, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01440.x · Cited by 158
Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis
Sharp, R., Recio, J. A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L. J., et al. (2002) · Nature Medicine · doi:10.1038/nm787 · Cited by 158
Camp, R. L., Rimm, E. B., & Rimm, D. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2 · Cited by 157
Schiering, N., Knapp, S., Marconi, M., Flocco, M. M., Cui, J., Perego, R., Rusconi, L., & Cristiani, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734128100 · Cited by 156
Liu, Z., Yu, C. F., Nickel, C. H., Thomas, S. Μ., & Cantley, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107551200 · Cited by 153
Tomioka, D., Maehara, N., Kuba, K., Mizumoto, K., Tanaka, M., Matsumoto, K., & Nakamura, T. (2001) · PubMed · Cited by 151
K252a inhibits the oncogenic properties of Met, the HGF receptor
Morotti, A., Mila, S., Accornero, P., Tagliabue, E., & Ponzetto, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205622 · Cited by 149
Sakkab, D., Lewitzky, M., Posern, G., Schaeper, U., Sachs, M., Birchmeier, W., & Feller, S. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10772 · Cited by 143
Wojta, J., Kaun, C., Breuss, J. M., Koshelnick, Y., Beckmann, R., Hattey, E., Mildner, M., Weninger, W., Nakamura, T., Tschachler, E., et al. (1999) · PubMed · Cited by 139
Kiss, A., Wang, N. J., Xie, J. P., & Thorgeirsson, S. S. (1997) · PubMed · Cited by 135
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.
Furukawa, T., Duguid, W. P., Kobari, M., Matsuno, S., & Tsao, M. (1995) · Europe PMC (PubMed Central) · Cited by 133
Børset, M., Lien, E., Espevik, T., Helseth, E., Waage, A., & Sundan, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24655 · Cited by 131
Edakuni, G., Sasatomi, E., Satoh, T., Tokunaga, O., & Miyazaki, K. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01182.x · Cited by 130
Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents
Laird, A., & Cherrington, J. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.51 · Cited by 130
Expression of the C– Met Protooncogene in Human Hepatocellular Carcinoma
Suzuki, K., Hayashi, N., Yamada, Y., Yoshihara, H., Miyamoto, Y., Ito, Y., Ito, T., Katayama, K., Sasaki, Y., Ito, A., et al. (1994) · Hepatology · doi:10.1002/hep.1840200520 · Cited by 125
Lorenzato, A., Olivero, M., Patanè, S., Rosso, E., OLIARO, A., Comoglio, P. M., & Renzo, M. F. D. (2002) · PubMed · Cited by 124
Tsao, M., Liu, G., Chen, J.-R., et al. (1998) · Lung Cancer · doi:10.1016/s0169-5002(98)00007-5 · Cited by 123
Rodrigues, G. A., & Park, M. (1994) · PubMed · Cited by 121
Lamorte, L., Royal, I., Naujokas, M. A., & Park, M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-10-0477 · Cited by 120
Scatter factors and invasive growth
Comoglio, P. M., & Boccaccio, C. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0366 · Cited by 119
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
Liang, T. J., Reid, A. E., Xavier, R. J., Cardiff, R. D., & Wang, T. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118744 · Cited by 115
Horiguchi, N., Takayama, H., Toyoda, M., Otsuka, T., Fukusato, T., Merlino, G. T., Takagi, H., & Mori, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205248 · Cited by 115
Wang, X., Le, P., Liang, C., Chan, J., Kiewlich, D., Miller, T. M., Harris, D., Sun, L., Rice, A. G., Vasile, S., et al. (2003) · PubMed · Cited by 114
Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
Wagatsuma, S., Konno, R., Sato, S., & Yajima, A. (1998) · Cancer · Cited by 108
Bardelli, A., Longati, P., Gramaglia, D., Basilico, C., Tamagnone, L., Giordano, S., Ballinari, D., Michieli, P., & Comoglio, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14379 · Cited by 106
Noonan, F. P., Otsuka, T., Bang, S., Anver, M. R., & Merlino, G. T. (2000) · PubMed · Cited by 105
Gallego, M. I., Bierie, B., & Hennighausen, L. G. (2003) · Oncogene · doi:10.1038/sj.onc.1207063 · Cited by 104
Involvement of Cdc42 small G protein in cell-cell adhesion, migration and morphology of MDCK cells
Kodama, A., Takaishi, K., Nakano, K., Nishioka, H., & Takai, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202773 · Cited by 104
Tolnay, E., Kuhnen, C., Wiethege, T., König, J. E., Voß, B., & Müller, K.-M. (1998) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050171 · Cited by 103
Lamorte, L., Rodrigues, S., Sangwan, V., Turner, C. E., & Park, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-08-0497 · Cited by 103
Furge, K. A., Kiewlich, D., Le, P. T., Vo, M. N., Faure, M., Howlett, A. R., Lipson, K. E., Woude, G. F. V., & Webb, C. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191067898 · Cited by 101
Atabey, N., Gao, Y., Yao, Z., Breckenridge, D., Soon, L., Soriano, J. V., Burke, T. R., & Bottaro, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010202200 · Cited by 100
Takanami, I., Tanana, F., Hashizume, T., et al. (2009) · Oncology · doi:10.1159/000227594 · Cited by 100
Hov, H., Holt, R. U., Rø, T. B., Fagerli, U., Hjorth‐Hansen, H., Baykov, V., Christensen, J. G., Waage, A., Sundan, A., & Børset, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0874 · Cited by 97
Self-citationDifferential MAPK Pathways Utilized for HGF- and EGF-dependent Renal Epithelial Morphogenesis
Karihaloo, A. K., O’Rourke, D. A., Nickel, C. H., Spokes, K., & Cantley, L. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009963200 · Cited by 95
Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
Recio, J. A., Noonan, F. P., Takayama, H., Anver, M. R., Duray, P. H., Rush, W. L., Lindner, G., Fabo, E. C. D., DePinho, R. A., & Merlino, G. T. (2002) · PubMed · Cited by 93
Iwasaki, T., Hamano, T., Ogata, A., Hashimoto, N., Kitano, M., & Kakishita, E. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03364.x · Cited by 91
Gille, J., Khalik, M., König, V., & Kaufmann, R. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00418.x · Cited by 91
Lamszus, K., Jin, L., Fuchs, A., Shi, E., Chowdhury, S., Yao, Y., Polverini, P. J., Laterra, J., Goldberg, I. D., & Rosen, E. M. (1997) · PubMed · Cited by 90
Ljubimova, J. Y., Petrovic, L. M., Wilson, S. E., Geller, S. A., & Demetriou, A. A. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500111 · Cited by 87
Chen, H.-C., Chan, P.-C., Tang, M., Cheng, C.-H., & Chang, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25777 · Cited by 87
Aebersold, D. M., Kollár, A., Beer, K. T., Laissue, J. A., Greiner, R. H., & Djonov, V. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010220)96:1<41::aid-ijc5>3.0.co;2-f · Cited by 85
Purified Scatter Factor Stimulates Epithelial and Vascular Endothelial Cell Migration
Rosen, E. M., Meromsky, L., Setter, E., et al. (1990) · Experimental Biology and Medicine · doi:10.3181/00379727-195-43115 · Cited by 85
Nabeshima, K., Shimao, Y., Sato, S., Kataoka, H., MORIYAMA, T., Kawano, H., Wakisaka, S., & Koono, M. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.3010889.x · Cited by 82
Day, R. M., Cioce, V., Breckenridge, D., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202683 · Cited by 81
Nakopoulou, Gakiopoulou, Keramopoulos, Giannopoulou, Athanassiadou, Mavrommatis, & Davaris (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.00847.x · Cited by 79
Jiang, W. G., Grimshaw, D., Lane, J., Martin, T. A., Abounader, R., Laterra, J., Mansel, R. E., & Abounder, R. (2001) · PubMed · Cited by 79
Martin, T. A., Parr, C., Davies, G., Watkins, G., Lane, J., Matsumoto, K., Nakamura, T., Mansel, R. E., & Jiang, W. G. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg072 · Cited by 79
Maehara, N., Matsumoto, K., Kuba, K., Mizumoto, K., Tanaka, M., & Nakamura, T. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1682 · Cited by 78
Lai, J., Kao, S.-C., Jiang, S., Tang, M., Chan, P.-C., & Chen, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7474 · Cited by 77
Parr, C., Hiscox, S., Nakamura, T., Matsumoto, K., & Jiang, W. G. (2000) · International Journal of Cancer · Cited by 73
Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
Herynk, M. H., Stoeltzing, O., Reinmuth, N., Parikh, N. U., Abounader, R., Laterra, J., Radinsky, R., Ellis, L. M., & Gallick, G. E. (2003) · PubMed · Cited by 71
Moriyama, T., Kataoka, H., Tsubouchi, H., & Koono, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00949-a · Cited by 71
Laterra, J., Rosen, E. M., Nam, M. J., Ranganathan, S., Fielding, K., & Johnston, P. V. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6853 · Cited by 70
Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis
Webb, C. P., Taylor, G. A., Jeffers, M., Fiscella, M., Oskarsson, M. K., Resau, J. H., & Woude, G. V. (1998) · Oncogene · doi:10.1038/sj.onc.1202135 · Cited by 68
Nakanishi, K., Fujimoto, J., 植木, 孝., Kishimoto, K., Hashimoto-Tamaoki, T., Furuyama, J.-I., Itoh, T., Sasaki, Y., & Okamoto, E. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006685218766 · Cited by 65
Regulation of scatter factor production via a soluble inducing factor.
Rosen, E. M., Joseph, A., Jin, L., Rockwell, S., Elias, J. A., Knesel, J., Wines, J., McClellan, J. L., Kluger, M. J., & Goldberg, I. D. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.1.225 · Cited by 64
Maemondo, M., Narumi, K., Saijo, Y., Usui, K., Tahara, M., Tazawa, R., Hagiwara, K., Matsumoto, K., Nakamura, T., & Nukiwa, T. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0533 · Cited by 63
Aebersold, D. M., Landt, O., Berthou, S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206968 · Cited by 63
Matsumoto, K., Date, K., Shimura, H., & Nakamura, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb00281.x · Cited by 61
Lamorte, L., Kamikura, D. M., & Park, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203977 · Cited by 61
Kuba, K., Matsumoto, K., Ohnishi, K., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4034 · Cited by 58
Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer
Nagy, J., Curry, G., Hillan, K. J., McKay, I. C., Mallon, E., Purushotham, A. D., & George, W. D. (1996) · Surgical Oncology · doi:10.1016/s0960-7404(96)80017-x · Cited by 55
Parr, C., Davies, G., Nakamura, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5307 · Cited by 52
Galeazzi, E., Olivero, M., Gervasio, C. F., Stefani, A. D., Valente, G., Comoglio, P. M., Renzo, M. F. D., & Cortesina, G. (1997) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf02439745 · Cited by 50
Saga, Y., Mizukami, H., Suzuki, M., Urabe, M., Kume, A., Nakamura, T., Sato, I., & Ozawa, K. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301553 · Cited by 48
Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
Stabile, L. P., Lyker, J. S., Huang, L., & Siegfried, J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302169 · Cited by 47
Expression of c-Met in laryngeal carcinoma
Sawatsubashi, M., Sasatomi, E., Mizokami, H., Tokunaga, O., & Shin, T. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050174 · Cited by 46
Davies, G., Mason, M. D., Martin, T. A., Parr, C., Watkins, G., Lane, J., Matsumoto, K., Nakamura, T., & Jiang, W. G. (2003) · International Journal of Cancer · doi:10.1002/ijc.11220 · Cited by 45
Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4
Hiscox, S., Parr, C., Nakamura, T., et al. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006348317841 · Cited by 45
Nakabayashi, M., Morishita, R., Nakagami, H., et al. (2003) · Diabetologia · doi:10.1007/s00125-002-0954-y · Cited by 42
Oh, R. R., Park, J. Y., Lee, J. H., Shin, M. S., Kim, H. S., Lee, S., Kim, Y. S., Lee, S. H., Lee, S. N., Yang, Y. M., et al. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.100305.x · Cited by 42
Wullich, B., Sattler, H., Fischer, U., & Meese, E. (1994) · PubMed · Cited by 42
HGF/SF Activates Glycolysis and Oxidative Phosphorylation in DA3 Murine Mammary Cancer Cells
Kaplan, O., Firon, M., Vivi, A., Navon, G., & Tsarfaty, I. (2000) · Neoplasia · doi:10.1038/sj.neo.7900103 · Cited by 36
Alteration of Met protooncogene product expression and prognosis in breast carcinomas.
Tsarfaty, I., Alvord, W. G., Resau, J. H., et al. (1999) · PubMed · Cited by 36
Fournier, T. M., Lamorte, L., Maroun, C. R., Lupher, M., Band, H., Langdon, W. Y., & Park, M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3397 · Cited by 34
Jeffers, M., Rao, M. S. R., Rulong, S., Jk, R., Subbarao, V., Hudson, E., Woude, G. F. V., & Resau, J. (1996) · PubMed · Cited by 34
Hepatocyte Growth Factor/Scatter Factor: Structure, Function and Regulation by Glycosaminoglycans.
Richardson, L., SCHWALL, R. H., & Zioncheck, T. F. (1996) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.8.167 · Cited by 28
Immunohistochemical examination of c-Met protein expression in astrocytic tumors
Hirose, Y., Kojima, M., Sagoh, M., Murakami, H., Yoshida, K., Shimazaki, K., & Kawase, T. (1998) · Acta Neuropathologica · doi:10.1007/s004010050809 · Cited by 27
Evaluation of the tyrosine kinase domain of theMet Proto-oncogene in sporadic ovarian carcinomas
Tanyi, J. L., Tory, K., Rigó, J. J., Nagy, B., & Papp, Z. (1999) · Pathology & Oncology Research · doi:10.1053/paor.1999.0219 · Cited by 25
Shaharabany, M., Abramovitch, R., Kushnir, T., Tsarfaty, G., Ravid-Megido, M., Horev, J., Ron, R., Itzchak, Y., & Tsarfaty, I. (2001) · PubMed · Cited by 25
Missense Mutation of the MET Gene Detected in Human Glioma
Moon, Y.-W., Weil, R. J., Pack, S., Park, W.-S., Pak, E. D., Pham, T., Karkera, J. D., Kim, H.-K., Vortmeyer, A. O., Fuller, B. G., et al. (2000) · Modern Pathology · doi:10.1038/modpathol.3880177 · Cited by 22
Morimoto, A., Tada, K., Nakayama, Y., Kohno, K., Naito, S., Ono, M., & Kuwano, M. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02886.x · Cited by 21
Rosa, S. L., Uccella, S., Capella, C., Erba, S., & Sessa, F. (2000) · Endocrine Pathology · doi:10.1385/ep:11:4:315 · Cited by 16
[The expression of cMET/hepatocyte growth factor receptor in colorectal cancer].
Ajisaka, H., Nishimura, G., Tsuneda, A., Fujita, H., Michiwa, Y., Kawamura, T., Sato, T., Nojima, N., Fushida, S., Fujimura, T., et al. (1998) · PubMed · Cited by 5
Cited by
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Yakes, F. M., Chen, J., Tan, J., Yamaguchi, K., Shi, Y., Yu, P., Qian, F., Chu, F., Bentzien, F., Cancilla, B., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0264 · Cited by 1,336
Cui, J. J., Tran-Dubé, M., Shen, H., Nambu, M., Kung, P.-P., Pairish, M., Jia, L., Meng, J., Funk, L., Botrous, I., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007613 · Cited by 932
Self-citationZou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Self-citation
Metadata
- Authors
- Christensen, J. G., Burrows, J., & Salgia, R.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 225
- Issue
- 1
- Pages
- 1-26
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2096844786
- Cited by
- 513
- References
- 181
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.